JSC „IMUNOLITA“ – company perusing research and implanting research results in practice. “Imunolita” focus on long-term stem cell storage, developing new technologies and products for individual treatment.
JSC “Imunolita” policy:
- Stem cell bank – first licensed bank in The Baltic States. From spring 2006 JSC “Imunolita” offers a possibility to store stem cells in Lithuania – cord blood stem cells or/and regenerative stem cells from adipose tissue and other tissues.
- Stem cell research – long-term stem cell research, stem cell toxicity and novel drug preparation research.
- Imunotechnological research – research of autoimmune process, development and construction of autologous vaccines, development of individual anti-cancerous vaccines and novel cancer treatment technologies.
|

|